Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways

International Immunology

Volumn 17, Issue 4, 2005, Pages 351-363

  Lagaraine, Christine ^a   Hoarau, Cyrille ^a   Chabot, Valérie ^a,b   Velge Roussel, Florence ^a,c   Lebranchu, Yvon ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c UFR des sciences pharmaceutiques   (France)

Author keywords

Cell therapy; Immunosuppressive agent; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 10; MYCOPHENOLIC ACID;

ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EXPOSURE; ENDOCYTOSIS; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MICROSCOPY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; IMP DEHYDROGENASE; LYMPHOCYTE ACTIVATION; MYCOPHENOLIC ACID;

EID: 17644395221     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh215     Document Type: Article

References (49)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245.
3. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
4. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
5. Lechler, R., Ng, W. F. and Steinman, R. M. 2001. Dendritic cells in transplantation - friend or foe? Immunity 14:357.
6. Lu, L., McCaslin, D., Starzl, T. E. and Thomson, A. W. 1995. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539.
7. Fu, F., Li, Y., Qian, S. et al. 1996. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86 - ) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659.
8. Lutz, M. B., Kukutsch, N. A., Menges, M., Rossner, S. and Schuler, G. 2000. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30:1048.
9. Jonuleit, H., Schmitt, E., Steinbrink, K. and Enk, A. H. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:394.
10. Steinman, R. M. and Nussenzweig, M. C. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Nalt Acad. Sci. USA 99:351.
11. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H. and Jonuleit, H. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80:477.
12. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
13. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C. and Bhardwaj, N. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233.
14. Lagaraine, C. and Lebranchu, Y. 2003, Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation 75:37S.
15. Adu, D., Cross, J. and Jayne, D. R. 2001. Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus 10:203.
16. Mele, T. S. and Halloran, P. F. 2000. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47:215.
17. Allison, A. C. and Eugui, E. M. 2000. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85.
18. Mehling, A., Grabbe, S., Voskort, M., Schwarz, T., Luger, T. A. and Beissert, S. 2000. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 165:2374.
19. Colic, M., Stojic-Vukanic, Z., Pavlovic, B., Jandric, D. and Stefanoska, I. 2003. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin. Exp. Immunol. 134:63.
20. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109.
21. Bullingham, R. E., Nicholls, A. J. and Kamm, B. R. 1998. Clinical pharmacokinetics of mycophenolate mofetil. Clin. Pharmacokinet. 34:429.
22. Johnson, A. G., Rigby, R. J., Taylor, P. J. et al. 1999. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients. Clin. Pharmacol. Ther. 66:492.
23. Steinman, R. M. and Cohn, Z. A. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142.
24. Lutz, M. B. and Schuler, G. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:445.
25. Pedersen, A. E., Gad, M., Walter, M. R. and Claesson, M. H. 2004. Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-dihydroxyvitamin D(3). Immunol. Lett. 91:63.
26. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
27. Buelens, C., Willems, F., Delvaux, A. et al. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25:2668.
28. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
29. Thomson, A. W. and Lu, L. 1999. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68:1.
30. Nouri-Shirazi, M. and Guinet, E. 2002. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation 74:1035.
31. Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H., Melief, C. J. and Offringa, R. 2000. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95:3162.
32. Piemonti, L., Monti, P., Sironi, M. et al. 2000. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164:4443.
33. Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems, F., Haegeman, G. and Goldman, M. 1999. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 162: 2569.
34. Thomas, J. M., Contreras, J. L., Jiang, X. L. et al. 1999. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68:1660.
35. Coates, P. T., Barratt-Boyes, S. M., Donnenberg, A. D., Morelli, A. E., Murphey-Corb, M. and Thomson, A. W. 2002. Strategies for preclinical evaluation of dendritic cell subsets for promotion of transplant tolerance in the nonhuman primate. Hum. Immunol. 63:955.
36. Chiang, P. H., Wang, L., Liang, Y. et al. 2002. Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. Transplant. Proc. 34:1394.
37. Griffin, M. D., Lutz, W., Phan, V. A., Bachman, L. A., McKean, D. J. and Kumar, R. 2001. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl Acad. Sci. USA 98:6800.
38. Lechler, R. I. and Batchelor, J. R. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155:31.
39. Gould, D. S. and Auchincloss, H,, Jr. 1999. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol. Today 20:77.
40. Meier-Kriesche, H. U., Steffen, B. J., Hochberg, A. M. et al. 2003. Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 75:1341.
41. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
42. Risso, A., Smilovich, D., Capra, M. C. et al. 1991. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J. Immunol. 146:4105.
43. Hashemi, B. B., Penkala, J. E., Vens, C., Huls, H., Cubbage, M. and Sams, C. F. 1999. T cell activation responses are differentially regulated during clinorotation and in spaceflight. FASEB J. 13:2071.
44. Sallusto, F., Schaerli, P., Loetscher, P. et al. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760.
45. Sozzani, S., Allavena, P., D'Amico, G. et al. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083.
46. Curnock, A. P., Logan, M. K. and Ward, S. G. 2002. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 105:125.
47. Arrighi, J. F., Rebsamen, M., Rousset, F., Kindler, V. and Hauser, C. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 166:3837.
48. Dempsey, P. W., Doyle, S. E., He, J. Q. and Cheng, G. 2003. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14:193.
49. Takeda, K. and Akira, S. 2004. TLR signaling pathways. Semin. Immunol. 16:3.